Wikidata

(Q43654472)

English

Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB.

scientific article

In more languages

Statements

title
Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
main subject
NF-κB
0 references
inflammation
0 references
author name string
Niederberger E
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Vetter G
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Schmidtko A
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Schmidt H
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Euchenhofer C
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Bräutigam L
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Grösch S
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
Geisslinger G
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
publication date
1 July 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017
page(s)
1622-1624
1 reference
stated in
Europe PubMed Central
PubMed ID
11427506
retrieved
25 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43654472&oldid=2102344400"